ABSTRACT
in tropical countries, etc. increases risk 1.5 fold, whereas having a darker skin complexion and using protective glasses substantially decreased the risk of developing pterygium. Ultraviolet (UV) light is one of the major factors implicated in the pathogenesis of pterygium, but the mechanism by which UV 2 light induces this disease remains elusive. 2 Pterygium has invasive characteristics including dysplastic expression, local invasiveness, and a high recurrence rate following surgical excision.
The treatment of choice of pterygium is surgical, directed towards its excision, restoration of ocular surface integrity and prevention of recurrence. Surgical techniques include bare sclera excision, excision with simple conjunctival closure, excision with the administration of antimetabolite adjuvants, excision with conjunctival autograft and excision followed by amniotic membrane transplantation. Conjunctival autograft with sutures or fibrin glue is widely followed as a technique for the treatment of recurrent or advanced pterygium. The complications related to conjunctival autograft transplantation includes transient graft oedema, corneoscleral dellen, graft retraction, epithelial cysts, granuloma and graft retraction. A more significant complication such as graft necrosis may occur if the graft is not properly oriented or placed on a completely avascular zone.
Recurrent pterygium 3 presents a significant surgical problem. Conjunctival shortening or symblepharon caused by multiple surgeries is especially challenging. Repeated surgical intervention in the limbal area causes severe destruction of limbal barrier function. To overcome this complication, both reconstruction of limbal barrier and suppression of the subconjunctival fibrosis are required. Considering the importance of the limbus and its stem cells in the pathogenesis of the pterygium, and as healthy limbus acts as a barrier to conjunctival overgrowth, a new technique has been developed recently. In addition to the conjunctival autograft, a part of the limbal stem cells is included that aids in the complete anatomic and physiologic reconstruction of the excised pterygium area. This limbal reconstruction may reduce the recurrence rate.
A pterygial regrowth was considered as clinically significant recurrence when a surgical procedure was required to remove proliferating conjunctival tissue growing over the cornea. Three distinct morphologic recurrence patterns 4 were found: a. Regrowth Over the epithelial defect 4 : A completely defective epithelium on the graft can lead to aggressive fibrovascular growth, as frequently seen in bare sclera method, as the reproliferative tissue extended over the original site of the pterygium. Causes of the defect were wound dehiscence, primary graft failure, and a focal defect in the epithelial graft. Grafting of intact and healthy conjunctival epithelium acts as a tight barrier against abnormal fibrovascular proliferation and prevents the triggering of an aggressive epithelial regenerative signal. A small graft or excessive excision of surrounding conjunctiva can cause dehiscence. Dryness or irrigating solution can be toxic to the conjunctival epithelium. b. Transformation of the autologous conjunctival graft 4 into pterygial tissue: the presence of graft haemorrhage can later lead to fibrous proliferation and vasculature from graft though the haemorrhage gets well absorbed in early postop period. Recurrence was characterised by a very thin and mild growth pattern. The re-proliferating tissue didn't grow over the previous pterygial head margin. c. Regrowth from unexcised pterygial tissue: The remaining tissue originated from three sources -the remnant pterygial tissue around the superior or inferior border of the excision; the nasal margin of the excised pterygial tissue; and the tightly adherent pterygial tissue on the excised bed. The recurrent pterygial tissue usually adheres tightly to the surface and it cannot be easily removed.
METHODOLOGY
A prospective observational study was conducted among 40 patients with pterygium attending the outpatient department of Govt. Rajaji Hospital, Madurai. The inclusion criteria for the study was patients with advanced, recurrent pterygium in the age group 30-50 years with pterygium extending between the limbus and pupillary margin and over to the centre of cornea, patients with diminished vision due to astigmatism, due to corneal involvement or pupillary encroachment of pterygium, patients with progressive pterygium with ocular discomfort/restricted ocular motility and patients with recurrent pterygium (those who had undergone any one of pterygium surgery 1 -2 years back and now has regrowth).
Patients with ocular surface diseases, dry eyes, autoimmune disorders, history of trauma/any other ocular surgery other than for pterygium and with secondary pterygium due to chemical burns were excluded from the study. Patients with pseudo pterygium and glaucoma were also excluded from this study. Pre-operative evaluation to look for the extent of corneal invasion, conjunctival thickness, depth of corneal involvement, vascularity and intensity of pigmentation along the apex were done. Under peribulbar anaesthesia adopting strict aseptic precautions, Conjunctival autograft surgery including limbal stem cells was done in all cases of advanced, recurrent pterygium by a single surgeon under peribulbar anaesthesia adopting strict aseptic precautions. The pterygial tissue and the subconjunctival fibrovascular tissue were subsequently removed as broadly as possible. After complete and meticulous dissection of the head of the pterygium from the cornea, the body of the pterygium was dissected and excised using conjunctival scissors. The conjunctival autograft was harvested from the supero-temporal side of the same eye including 1.0 mm margin of the limbal conjunctiva (Fig:1) . Each graft was sutured using 10-0 nylon.
Fig. 1: Schematic Diagram showing Conjunctival Autograft including Limbal Stem Cells
Postoperative complications like graft oedema, graft retraction, graft necrosis, conjunctival granuloma and corneoscleral dellen. Care was taken to look for any defects in graft, proper positioning and apposition of graft edges, the presence of remnants or incompletely excised pterygial tissue under slit lamp postoperatively after fluorescein staining. Care was taken to check for the presence of factors contributing to recurrence. Despite the presence of contributing factors, further cases with recurrence were followed up. The best corrected visual acuity and keratometry was also determined in post-operative cases.
OBSERVATION AND ANALYSIS
In our study with 40 patients satisfying the inclusion and exclusion criteria, 65% of patients were males and 35% of patients were female. The increase in male patients was due to their outdoor activity and irrespective of gender, 42.5 % of patients were in the age group of 41-50 years, this prevalence correlates with the available literature. Pterygium was present on the right eye in 37.5%, on the left eye in 32.5% and on both eyes in 30%. It is a bilateral disease, other eye develops pterygium usually by some months to years after. 90% of pterygia were present on nasal side. 7.5% of pterygia were present on temporal side and 2.5% of pterygia were present on both sides. Mostly preferred nasal location is due to more exposure of nasal side to UV radiation.
Out of 40 patients, the grades of pterygium 5 were III in 32 patients (80%), IV in 2 patients (5%) and 6 patients (15%) with recurrent pterygium. Current indications for surgery was ocular discomfort (57.5%), for visual impairment (27.5%), and among them, two persons had grade IV pterygium with pupillary axis involvement. None of the patients reported for cosmetic disfigurement. 45% of patients presented with uncorrected visual acuity (UCVA) of 6/36 -6/24, 25% of patients presented with UCVA of 6/18 -6/12 (Fig: 2) . Patients with 6/60 and below also presented with cataract changes in their lens. In 95 % of patients, the presence of Grade III and Grade IV pterygium or recurrent pterygium was associated with astigmatism measured by manual keratometry. Postoperatively, two patients presented with graft oedema on their post-operative week, graft retraction in one patient and conjunctival granuloma (Fig: 3) in two patients. There was no single case who developed dellen or graft necrosis. 97.5% of patients had no astigmatism postoperatively. 90% of patients had improvement in their visual acuity by one or two lines with Snellen's chart (Fig: 4) . Mid 'p' value of < 0.005 shows there is statistical significance among preoperative and postoperative visual acuity and astigmatism with a low recurrence of pterygium (Fig: 5) .
There was no evidence of any limbal scar or pseudopterygium noted in the donor area in our study patients. Postoperative complications were minimal and they were managed by simple procedures. Despite being a timeconsuming procedure, based on the above observations, limbal conjunctival autograft transplantation in advanced, recurrent pterygium is a safe and effective procedure with low recurrence rate and minimal complications.
DISCUSSION
Pterygium is a worldwide conjunctival degenerative disease of multifactorial origin. Limbal cells alteration plays a major role in the aetiopathogenesis of pterygium. Despite various surgical procedures available for treatment of pterygium, recurrence remains the single and enigmatic complication for pterygium surgery.
Recurrent pterygium is difficult to treat. Radiotherapy, antimetabolites, and conjunctival limbal autograft have been proposed for treating recurrent pterygium. Antimetabolites 6 usage is sometimes associated with complications like scleral ulceration, necrosis, secondary glaucoma, corneal perforation, cataract formation, iritis and irreversibly damaged limbal 
CONCLUSION
The study on the efficacy of conjunctival autograft surgery with limbal stem cells in patients with advanced, recurrent pterygium shows statistically significant results in improvement of visual acuity with a low recurrence.
